BUY Cipla Ltd. — Prabhudas Lilladher
byPrabhudas LilladherHorizon: NA (inferred 1 year)24 Jul 2026via Moneycontrol Broker Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Cipla's US Milestone Gets The Street Talking. Analysts See Bigger Opportunity Ahead
NewsNdtv-Profit·29 Jul · today
Nearly four years late. But perhaps arriving at the perfect time
NewsCnbc-Tv18·28 Jul · today
8 other SEBI-registered advisors have active long-term BUY calls on this stock, with 4 issued in the last 14 days
Advisor consensus · same horizon·29 Jul · today
Cipla secures USFDA approval for generic Advair Diskus in all three strengths
NewsCnbc-Tv18·27 Jul · yesterday
Earning Estimates: Infosys, Cipla, IndiGo, Meesho, Mphasis & Allied Blenders Q1 Results Today — What To Expect
NewsNdtv-Profit·23 Jul · 6d ago
Cipla Ltd announces a change in its Chief Financial Officer (CFO) role. Mr. Ashish Adukia transitions to an internal business leadership role, relinquishing his CFO position. Mr. Dinesh Jain is appoin
BSE · Company Update·23 Jul · 5d ago
Cipla Ltd announced changes in its finance leadership. Mr. Ashish Adukia transitions from Global CFO to an internal business leadership role, relinquishing his KMP position. Mr. Dinesh Jain is appoint
BSE · Board Meeting·23 Jul · 5d ago
Cipla announced changes in its finance leadership. Ashish Adukia transitions from Global CFO to an internal role, and Dinesh Jain is appointed as the new Global CFO and KMP, effective July 24, 2026.
NSE · Outcome of Board Meeting·23 Jul · 5d ago
Cipla Limited announced its unaudited consolidated financial results for the quarter ended June 30, 2026. The company reported total income from operations of INR 7,119 Cr, EBITDA of INR 1,192 Cr, and
NSE · Press Release·23 Jul · 5d ago
Cipla Ltd announced its unaudited consolidated financial results for the quarter ended June 30, 2026. The company reported total income from operations of INR 7,119 Cr, EBITDA of INR 1,192 Cr, and PAT
BSE · Company Update·23 Jul · 5d ago
US market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipeline
NewsEt-Markets·27 Jul · 2d ago
Cipla shares rise 3.7% despite Q1 profit fall, brokerages remain cautious
NewsHbl·24 Jul · 5d ago
Cipla Q1 results: Profit falls 39% YoY to ₹789.05 crore
NewsLivemint·23 Jul · 5d ago
Cipla Shares Fall 2% After Q1 Profit Declines Nearly 40%
NewsNdtv-Profit·23 Jul · 5d ago
Sensex, Nifty sink below key EMAs at midday; Adani Enterprises, Cipla lead losses
NewsHbl·23 Jul · 5d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Cipla
- BUY — Ashish Bahety, Profitmart Securities29 Sept 2026 · Same day · target ₹1,420 · Expired
- BUY — Ashish Bahety, Profitmart Securities29 Sept 2026 · Same day · target ₹1,430 · Expired
- BUY — Rajesh Palviya, Axis Securities29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY — Arun Kumar Mantri28 Sept 2026 · ~1 year · target ₹1,900 · Active
- BUY — Arun Kumar Mantri25 Sept 2026 · Same day · target ₹1,428 · SL hit
More from Prabhudas Lilladher
- BUY Sai Life Sciences21 Oct 2026 · ~1 year · target ₹1,620 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹200 · Active
- BUY Nestle India15 Oct 2026 · ~1 year · target ₹1,526 · Active
- BUY Tata Elxsi14 Oct 2026 · ~1 year · target ₹3,790 · Target hit
- SELL Avenue Supermarts12 Oct 2026 · ~3 months · target ₹3,214 · Target hit

